Peptide-pulsed dendritic cell vaccination targeting interleukin-13 receptor α2 chain in recurrent malignant glioma patients with HLA-A24/A02 allele

Kenichiro IwamiDepartment of Neurosurgery, Nagoya University School of Medicine, Nagoya, Japan

Shinji ShimatoDepartment of Neurosurgery, Nagoya University School of Medicine, Nagoya, Japan

Masasuke OhnoDepartment of Neurosurgery, Nagoya University School of Medicine, Nagoya, Japan

Hideho OkadaDepartment of Neurological Surgery, University of Pittsburgh, Pennsylvania, USA

Norimoto NakaharaDepartment of Neurosurgery, Nagoya University School of Medicine, Nagoya, Japan

Yuichiro SatoDepartment of Neurosurgery, Nagoya University School of Medicine, Nagoya, Japan

Jun YoshidaDepartment of Neurosurgery, Nagoya University School of Medicine, Nagoya, Japan

Satoshi SuzukiCenter for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan

Hiroyoshi NishikawaDepartment of Experimental Immunology, Immunology Frontier Research Center, Osaka University, Osaka, Japan

Hiroshi ShikuDepartment of Cancer Vaccine, Mie University School of Medicine, Tsu, Japan

Atsushi NatsumeDepartment of Neurosurgery, Nagoya University School of Medicine, Nagoya, JapanCorrespondence[email protected]

Toshihiko WakabayashiDepartment of Neurosurgery, Nagoya University School of Medicine, Nagoya, Japan

Your download is now in progress and you may close this window